ACLARION INC (ACON)
US6551872012 - Common Stock
We assign a fundamental rating of 1 out of 10 to ACON. ACON was compared to 40 industry peers in the Health Care Technology industry. ACON may be in some trouble as it scores bad on both profitability and health. ACON has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
ACON had negative earnings in the past year.
ACON had a negative operating cash flow in the past year.
1.2 Ratios
The Return On Assets of ACON (-199.42%) is worse than 89.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -199.42% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-257.35%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 5.23%, ACON is not doing good in the industry: 94.87% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for ACON so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 5.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ACON does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACON has less shares outstanding than it did 1 year ago.
ACON has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -32.24, we must say that ACON is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ACON (-32.24) is worse than 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -32.24 |
ROIC/WACCN/A
WACC10.12%
2.3 Liquidity
ACON has a Current Ratio of 0.40. This is a bad value and indicates that ACON is not financially healthy enough and could expect problems in meeting its short term obligations.
ACON has a Current ratio of 0.40. This is amonst the worse of the industry: ACON underperforms 87.18% of its industry peers.
ACON has a Quick Ratio of 0.40. This is a bad value and indicates that ACON is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.40, ACON is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.4 | ||
| Quick Ratio | 0.4 |
3. Growth
3.1 Past
ACON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.87%.
The Revenue has grown by 39.67% in the past year. This is a very strong growth!
The Revenue has been growing by 14.67% on average over the past years. This is quite good.
EPS 1Y (TTM)-14.87%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-2172.5%
Revenue 1Y (TTM)39.67%
Revenue growth 3Y14.67%
Revenue growth 5YN/A
Revenue growth Q2Q-31%
3.2 Future
ACON is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -16.98% yearly.
Based on estimates for the next years, ACON will show a small growth in Revenue. The Revenue will grow by 4.08% on average per year.
EPS Next Y-200%
EPS Next 2Y-16.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-74%
Revenue Next 2Y4.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ACON. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACON. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ACON's earnings are expected to decrease with -16.98% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.98%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ACON!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ACLARION INC
NASDAQ:ACON (5/2/2024, 5:05:42 PM)
After market: 0.283 +0 (+0.07%)0.2828
-0.01 (-3.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.02M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -199.42% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 5.23% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.4 | ||
| Quick Ratio | 0.4 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-14.87%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-200%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)39.67%
Revenue growth 3Y14.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y